Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Rivaroxaban

Rivaroxaban Range

Comprehensive Rivaroxaban portfolio for Franchise & Manufacturing.

Category
rivaroxaban
Total Formulations
5
Available Forms
Tablets
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Rivaroxaban portfolio by Dosage Form

Tablets

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Rivaroxaban batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Rivaroxaban PCD Pharma Franchise Company

Rivaroxaban PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Rivaroxaban PCD pharma franchise company offering 5 WHO-GMP certified Rivaroxaban formulations. We provide district-wise monopoly rights, quality-assured products and complete promotional support to pharma distributors, franchise partners and marketing professionals across India.

What is Rivaroxaban?

Rivaroxaban is a direct oral anticoagulant that selectively inhibits factor Xa, reducing the formation of blood clots. It is a prescription-only medicine that must be used under close medical supervision because of bleeding risk. Reference data is available on PubChem.

Available Rivaroxaban Formulations

Our Rivaroxaban portfolio spans 5 formulations available in Tablet form. This range lets franchise partners serve multiple prescriber and patient segments from a single dependable supplier, with consistent quality across every batch.

Therapeutic Applications

Rivaroxaban is used to prevent and treat deep vein thrombosis and pulmonary embolism and to reduce stroke risk in non-valvular atrial fibrillation. It is prescribed and monitored by cardiologists and physicians, with dosing individualised to the indication.

Why Rivaroxaban is a High-Potential Molecule for Distributors

Oral anticoagulants like Rivaroxaban are increasingly preferred over older agents for their convenience and are used long term in a growing atrial-fibrillation and thrombosis population, driving durable demand. Distributors serving cardiology and general medicine can build a steady, high-value chronic-therapy segment.

Why Choose Cafoli Lifecare

As a WHO-GMP certified and DCGI-approved pharma company, Cafoli Lifecare gives franchise partners district-wise monopoly rights, quality-assured products, attractive margins and complete promotional inputs including visual aids, product cards and marketing support. With a network of 1000+ partners across India, we combine dependable supply with genuine on-ground support to help you grow.

References

  1. PubChem - Rivaroxaban
  2. PubMed - Rivaroxaban clinical literature

Aceclofenac in Modern Clinical Practice

Our formulations of Rivaroxaban find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Rivaroxaban in PCD Franchise

Start Your Rivaroxaban Franchise with Cafoli Lifecare

Ready to launch your Rivaroxaban PCD pharma franchise with monopoly rights and full promotional support? Call +91 95184 47302 or email info@cafoli.in to get started.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 5 WHO-GMP certified Rivaroxaban tablet formulations for the prevention and treatment of blood clots.

Yes. We grant district-wise monopoly rights so each franchise partner markets Rivaroxaban exclusively within their allotted territory.

Rivaroxaban is prescribed by cardiologists and consulting physicians managing atrial fibrillation, deep vein thrombosis and pulmonary embolism.

Rivaroxaban increases bleeding risk, so it must be taken exactly as prescribed and never stopped abruptly without medical advice. It is a strictly prescription-only medicine used under specialist supervision.

A valid Drug License and GST registration are required to appoint a Rivaroxaban PCD franchise with Cafoli Lifecare.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited